002044 美年健康
2026/09 - 九个月
人民幣(K¥)
与去年同期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
营业总收入6,583,154-4.94%10,359,53110,701,99110,893,5358,615,698
减:营业总成本6,317,363-6.38%9,639,1139,931,1659,995,3758,861,468
    其中:营业成本4,025,800-5.74%6,074,9096,123,3396,232,3145,648,821
               财务费用200,367-12.76%302,073314,819299,024288,687
               资产减值损失----(60,052)(40,485)(88,787)(36,148)
公允价值变动收益(13,700)-142.16%25,4304,41141,90319,045
投资收益83731.93%35,13312,4497,578(3,620)
    其中:对联营企业和合营企业的投资收益(11,147)-37.83%17,089(16,627)(9,376)(46,126)
营业利润218,11633.06%597,824612,591883,705(407,657)
利润总额208,67850.86%557,451592,518848,055(450,720)
减:所得税费用82,79776.66%186,866183,528179,23250,862
净利润125,88137.64%370,585408,990668,823(501,582)
减:非控股权益29,476-25.57%85,258126,752163,20257,439
股东净利润96,40685.90%285,327282,238505,621(559,020)

市场价值指针
每股收益 (元) *0.020100.00%0.0700.0700.130-0.140
每股派息 (元) *----0.0090.0140.019--
每股净资产 (元) *2.1034.11%2.0782.0211.9671.905
审计意见 #--标准的无保留意见标准的无保留意见标准的无保留意见标准的无保留意见
回页顶
备注: *未调整数据
#只提供简体内容